- Home
- ROIV vs KIM Comparison
ROIV vs KIM Comparison
Compare ROIV & KIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- KIM
- Stock Information
- Founded
- ROIV 2014
- KIM 1958
- Country
- ROIV United Kingdom
- KIM United States
- Employees
- ROIV 750
- KIM N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- KIM Real Estate Investment Trusts
- Sector
- ROIV Health Care
- KIM Real Estate
- Exchange
- ROIV Nasdaq
- KIM Nasdaq
- Market Cap
- ROIV 14.1B
- KIM 14.1B
- IPO Year
- ROIV N/A
- KIM 1991
- Fundamental
- Price
- ROIV $20.73
- KIM $20.76
- Analyst Decision
- ROIV Strong Buy
- KIM Buy
- Analyst Count
- ROIV 8
- KIM 10
- Target Price
- ROIV $21.19
- KIM $24.20
- AVG Volume (30 Days)
- ROIV 8.4M
- KIM 5.4M
- Earning Date
- ROIV 11-10-2025
- KIM 10-30-2025
- Dividend Yield
- ROIV N/A
- KIM 5.09%
- EPS Growth
- ROIV N/A
- KIM 57.13
- EPS
- ROIV N/A
- KIM 0.83
- Revenue
- ROIV $20,329,000.00
- KIM $2,123,057,000.00
- Revenue This Year
- ROIV N/A
- KIM $4.86
- Revenue Next Year
- ROIV $320.50
- KIM $3.18
- P/E Ratio
- ROIV N/A
- KIM $24.59
- Revenue Growth
- ROIV N/A
- KIM 8.14
- 52 Week Low
- ROIV $8.73
- KIM $17.93
- 52 Week High
- ROIV $21.35
- KIM $25.83
- Technical
- Relative Strength Index (RSI)
- ROIV 66.63
- KIM 49.94
- Support Level
- ROIV $19.99
- KIM $19.86
- Resistance Level
- ROIV $20.99
- KIM $20.80
- Average True Range (ATR)
- ROIV 0.74
- KIM 0.35
- MACD
- ROIV -0.19
- KIM 0.05
- Stochastic Oscillator
- ROIV 56.41
- KIM 93.58
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About KIM Kimco Realty Corporation (HC)
One of the oldest real estate investment trusts in the United States, Kimco Realty owns interests in 567 shopping centers throughout major markets in the US, representing roughly 101 million square feet.